Bioventus Inc. - Class A Common Stock — Bilan (NASDAQ:BVS) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes

Trimestriel Annuel

Total de l'actif 1.23 B1.37 B810.91 M727.96 M683.56 M Total du passif 692.07 M1.03 B589.79 M542.35 M455.11 M Total des capitaux propres 533.79 M340.33 M221.12 M185.6 M228.45 M Total du passif et des capitaux propres 1.23 B1.37 B810.91 M727.96 M683.56 M Dette totale 339.64 M385.01 M367 M308.29 M294.86 M Dette nette 339.64 M385.01 M367 M308.29 M227.71 M

Nouvelles

Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Is Bioventus (BVS) Stock Undervalued Right Now?

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?

Bioventus T1 2026 : des résultats solides entraînent une révision à la hausse des prévisions

Bioventus (BVS) Surpasses Q1 Earnings and Revenue Estimates

Should Value Investors Buy Bioventus (BVS) Stock?

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?

Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength?

Are Investors Undervaluing Bioventus (BVS) Right Now?

L’action Bioventus affiche un rendement de 63% après le signal de Juste Valeur